US Vaccine Policy Update: ACIP Charter Re-Established, HHS Reshuffling, and Ebola Outbreak Implications (cidrap.umn.edu)

• HHS re-established ACIP charter on May 19, 2026
• WHO advises against broad Ervebo use against Bundibugyo
• Two Bundibugyo-specific vaccines prioritized
• Iowa restricts teen HPV and hep B vaccines without parental consent
• Gavi provides timeline to phase out thimerosal-containing vaccines

"This CIDRAP analysis covers recent developments in US vaccine policy including HHS personnel changes, the re-establishment of the ACIP charter, and state-level vaccine legislation. The article also reports on the ongoing Ebola outbreak in DRC, noting that WHO advises against broad use of existing Ervebo vaccine due to cross-protection concerns against the Bundibugyo virus. Two Bundibugyo-specific vaccines are prioritized for development. The piece highlights global vulnerabilities exposed by the outbreak and US funding cuts to multilateral health bodies like Gavi. It also notes VRBPAC's meeting on fall COVID-19 vaccine formulation and retractions of vaccine-skeptical studies."